Efficacy News and Research

RSS
FDA approves Sprycel for treatment of adults with Ph+ CP-CML

FDA approves Sprycel for treatment of adults with Ph+ CP-CML

StemCells initiates HuCNS-SC second clinical trial for Batten disease in children

StemCells initiates HuCNS-SC second clinical trial for Batten disease in children

Pfizer announces approval of Lyrica capsules for peripheral neuropathic pain

Pfizer announces approval of Lyrica capsules for peripheral neuropathic pain

Geron 2010 third quarter revenue increases from $494,000 to $546,000

Geron 2010 third quarter revenue increases from $494,000 to $546,000

Pain Therapeutics third quarter net loss decreases from $1.3 million to $1.0 million

Pain Therapeutics third quarter net loss decreases from $1.3 million to $1.0 million

Neurocrine third quarter revenue increases from $0.7 million to $14.4 million

Neurocrine third quarter revenue increases from $0.7 million to $14.4 million

Antigenics third quarter net loss decreases from $10.8 million to $5.9 million

Antigenics third quarter net loss decreases from $10.8 million to $5.9 million

CCS presents new 2010 Atrial Fibrillation Guidelines

CCS presents new 2010 Atrial Fibrillation Guidelines

RExpert to discuss latest advancements in musculoskeletal bioengineering at NCKU International Symposium

RExpert to discuss latest advancements in musculoskeletal bioengineering at NCKU International Symposium

Pharmasset's PSI-938 phase I monotherapy trial shows positive result for HCV treatment

Pharmasset's PSI-938 phase I monotherapy trial shows positive result for HCV treatment

BioCryst 2010 third quarter revenue increases from $10.5 million to $12.0 million

BioCryst 2010 third quarter revenue increases from $10.5 million to $12.0 million

QLT expands QLT091001 Phase 1b LCA study to include patients with Retinitis Pigmentosa

QLT expands QLT091001 Phase 1b LCA study to include patients with Retinitis Pigmentosa

Octapharma initiates Human-cl rhFVIII clinical study for severe hemophilia A

Octapharma initiates Human-cl rhFVIII clinical study for severe hemophilia A

CECOLFES fertility treatment results demonstrate effectiveness of INVOcell cycle process

CECOLFES fertility treatment results demonstrate effectiveness of INVOcell cycle process

Pfizer announces publication of crizotinib data for NSCLC patients in New England Journal of Medicine

Pfizer announces publication of crizotinib data for NSCLC patients in New England Journal of Medicine

Immune system may play a role in cancer therapies: Study

Immune system may play a role in cancer therapies: Study

ChemoCentryx reports one-year study results of Traficet-EN in Crohn's disease patients

ChemoCentryx reports one-year study results of Traficet-EN in Crohn's disease patients

EpiCept, FDA reach agreement on regulatory path forward for Ceplene

EpiCept, FDA reach agreement on regulatory path forward for Ceplene

Nymox updates NX-1207 Phase 3 pivotal trials for benign prostatic hyperplasia

Nymox updates NX-1207 Phase 3 pivotal trials for benign prostatic hyperplasia

Health Canada approves PRADAX anticoagulant for stroke prevention in AF patients

Health Canada approves PRADAX anticoagulant for stroke prevention in AF patients

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.